125 related articles for article (PubMed ID: 37393834)
21. miRNA-338-3p inhibits the migration, invasion and proliferation of human lung adenocarcinoma cells by targeting MAP3K2.
Zhang B; Wang D; Wang Y; Chen G
Aging (Albany NY); 2022 Aug; 14(15):6094-6110. PubMed ID: 35929837
[TBL] [Abstract][Full Text] [Related]
22. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
[TBL] [Abstract][Full Text] [Related]
23. [Research on the mechanism of hypoxia promoting the migration of lung adenocarcinoma A549 cells].
Jin JH; Zhao BS; Liu YZ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Jan; 38(1):68-74. PubMed ID: 35634673
[No Abstract] [Full Text] [Related]
24. TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
Wang J; Pan X; Li J; Zhao J
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485284
[TBL] [Abstract][Full Text] [Related]
25. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
Sun X; Wang R; Tan M; Tian X; Meng J
Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
[TBL] [Abstract][Full Text] [Related]
26. Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.
Xu L; Zhang X; Wang Z; Zhao X; Zhao L; Hu Y
Am J Transl Res; 2021; 13(4):2060-2076. PubMed ID: 34017375
[TBL] [Abstract][Full Text] [Related]
27. microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells.
Chen C; Zhao Z; Liu Y; Mu D
Oncol Lett; 2015 Mar; 9(3):1128-1134. PubMed ID: 25663868
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
Hu B; Zhu X; Lu J
Mol Med Rep; 2020 Jun; 21(6):2553-2559. PubMed ID: 32323791
[TBL] [Abstract][Full Text] [Related]
29. Silencing of
An W; Yu F
Open Med (Wars); 2022; 17(1):1655-1663. PubMed ID: 36349192
[TBL] [Abstract][Full Text] [Related]
30. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
31. LncRNA SLC7A11-AS1 Contributes to Lung Cancer Progression Through Facilitating TRAIP Expression by Inhibiting miR-4775.
Liu Y; Fan X; Zhao Z; Shan X
Onco Targets Ther; 2020; 13():6295-6302. PubMed ID: 32636648
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Kelch-like epichlorohydrin-related protein 1 promotes the progression and drug resistance of lung adenocarcinoma.
Gao H; Tang P; Ni K; Zhu L; Chen S; Zheng Y; Wan Y
PeerJ; 2021; 9():e11908. PubMed ID: 34466284
[TBL] [Abstract][Full Text] [Related]
33. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
35. [Puerarin Inhibits the Proliferation,Invasion,and Migration of Non-small Cell Lung Cancer Cells through Regulating miR-490/Denticleless E3 Ubiquitin Protein Ligase].
Zhang YX; Zhang ZZ; Zhao LG; Zhao LL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):91-101. PubMed ID: 35300770
[TBL] [Abstract][Full Text] [Related]
36. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
37. NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma.
Wei S; Xing J; Lu K; Wang K; Yu W
Hereditas; 2023 May; 160(1):27. PubMed ID: 37254219
[TBL] [Abstract][Full Text] [Related]
38. STAMBPL1 knockdown has antitumour effects on gastric cancer biological activities.
Yu DJ; Qian J; Jin X; Li J; Guo CX; Yue XC
Oncol Lett; 2019 Nov; 18(5):4421-4428. PubMed ID: 31611951
[TBL] [Abstract][Full Text] [Related]
39. Circle RNA FOXP1 promotes cell proliferation in lung cancer by regulating miR-185-5p/Wnt1 signaling pathway.
Li O; Kang J; Zhang JJ; Wang J; Hu LW; Li L; Sun YY; Bai Y; Wei QQ; Yan YP; Yi X
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6767-6778. PubMed ID: 32633368
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of
Ren P; Zhai J; Wang X; Yin Y; Lin Z; Cai K; Wang H
Transl Lung Cancer Res; 2023 May; 12(5):1051-1061. PubMed ID: 37323178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
